FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

LZI Buprenorphine II Enzyme Immunoassay

K Number: K253082 · Decision Jan 16, 2026
Classifications
1
FEI Numbers
100
Registration Numbers
100
Same Product Code
214
Applicant Total
50
Review Days
115

Basic Information

Device Name
LZI Buprenorphine II Enzyme Immunoassay
K Number
K253082
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
862.3650
Medical Specialty
Clinical Toxicology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Lin-Zhi International, Inc.
Date Received
September 23, 2025
Decision Date
January 16, 2026
Product Code
DJG
Advisory Committee
Clinical Toxicology
Review Advisory Committee
TX
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
DJG Enzyme Immunoassay, Opiates

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (DJG), ordered by most recent decision date.

View all

Other Clearances by Lin-Zhi International, Inc.

K Number Device Name
K251634 LZI Fentanyl III Enzyme Immunoassay
K202007 LZI Oxycodone III Enzyme Immunoassay
K201938 LZI Fentanyl II Enzyme Immunoassay
K201223 LZI Tramadol Enzyme Immunoassay
K192299 LZI Cotinine II Enzyme Immunoassay
K192433 LZI Methadone II Enzyme Immunoassay
K181159 LZI Fentanyl Enzyme Immunoassay
DEN170010 LZI Carisoprodol Metabolite (Meprobamate) Enzyme Immunoassay
K170416 LZI Methadone Metabolite Enzyme Immunoassay, LZI Methadone Metabolite (100 and 300) Calibrators
K141320 LZI Oral Fluid Cannabinoids Enzyme Immunoassay, LZI Oral Fluid Cannabinoids Calibrators and LZI Oral Fluid Cannabinoids Controls
Search all 50 clearances from Lin-Zhi International, Inc. →